The term “liberated information” may sound like it was taken from a science fiction novel, but to General Electric’s (NYSE:GE) Earl Jones, it’s a means to improve access and quality to healthcare while at the same time making it cheaper. Jones is the vice president and general manager of the eHealth division of GE Healthcare, overseeing the development of information technology platforms that customers ranging from small doctors’ offices to state governments are implementing into their everyday operations.
The man Stanford University once dubbed “The Mickey Mantle of medical device inventors” still has his swing, or at least his sway in the industry, judging by the reaction Dr. Thomas Fogarty received in Boston recently at a round-table discussion of medical device innovation.
For William Hawkins, Medtronic Inc. (NYSE:MDT) runs in the family.
Inside his corner office at the Fridley, Minn.-based medical device goliath, Hawkins, chairman and CEO of one of the world’s largest medical device companies, keeps a picture of two customers he says not only shaped how he sees his company but how he sees the world.
InfraReDx Inc. is on a roll this fall. The Burlington, Mass.-based medical device maker won 510(k) clearance from the Food & Drug Administration in early September for its LipiScan IVUS coronary imaging system and pulled in $21 million in an equity offering a month later, which it plans to use to fund the U.S. rollout of the device.
The LipiScan IVUS uses both so-called “near-infrared” spectroscopy and intravascular ultrasound technology to give cardiologists a grayscale IVUS image of a coronary artery, along with a map of lipid core coronary plaques within a blood vessel.